Purpose: To determine the relationship between the rate of glaucomatous visual field loss and the amplitude of a 24-h intraocular pressure (IOP)-related profile measured using a contact lens sensor (CLS). Methods: This observational study included 22 patients with glaucoma and an IOP of consistently ≤21 mm Hg during office hours. All subjects underwent Goldmann tonometry, standard automated perimetry (SAP), dilated fundus examination, and had a CLS recording. A cosine function was used to obtain peak (acrophase), trough (bathyphase), and amplitude measurements. Prior rates of change in SAP mean deviation were calculated and compared to CLS parameters. Results: The patients had a mean (± SD) age of 66.6 ± 8.2 years (range 54-89 years). Mean follow-up was 6.6 ± 5.0 years with 8.3 ± 3.2 reliable SAP tests. The mean rate of change in SAP was -0.86 ± 1.0 dB per year (range -0.11 to -2.12 dB). Regression analysis suggested faster rates of prior visual field loss in eyes with higher-amplitude CLS curves, but this did not reach statistical significance (R2 = 0.174, p = 0.053). The CLS accurately identified waking and sleeping periods. 59.1% of eyes had a nocturnal acrophase (peaking between 23:00 and 07:00). There was no significant difference in rates of visual field change between patients with nocturnal or diurnal acrophase (-0.71 ± 1.17 and -1.07 ± 0.84 dB/year, respectively, p = 0.437). Conclusion: CLS recordings in patients with normal-tension glaucoma (defined by office hours IOP) indicated that 60% of patients had peak IOP during nocturnal hours, which may not be captured using conventional methods of IOP measurement. Novel parameters obtained using the CLS may provide information for predicting the risk of visual field changes for patients with glaucoma.

Weinreb RN, Aung T, Medeiros FA: The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311:1901-1911.
Liu JH, Zhang X, Kripke DF, Weinreb RN: Twenty-four-hour intraocular pressure pattern associated with early glaucomatous changes. Invest Ophthalmol Vis Sci 2003;44:1586-1590.
Barkana Y, Anis S, Liebmann J Liebmann J, Tello C, Ritch R: Clinical utility of intraocular pressure monitoring outside of normal office hours in patients with glaucoma. Arch Ophthalmol 2006;124:793-797.
Coleman DJ, Troket S: Direct-recorded intraocular pressure variations in a human subject. Arch Opthalmol 1969;82:637-640.
Sanchez I, Laukhin V, Moya A, Martin R, Ussa F, et al: Prototype of a nanostructured sensing contact lens for non-invasive intraocular pressure monitoring. Invest Opthalmol Vis Sci 2011;52:8310-8315.
Nakakura S, Nomura Y, Ataka S, Shiraki K: Relation between office intraocular pressure and 24-h intraocular pressure in patients with primary open-angle glaucoma treated with a combination of topical antiglaucoma eye drops. J Glaucoma 2007;16:201-204.
Klein BEK, Klien R, Knudtson MD: Intraocular pressure and systemic blood pressure: longitudinal perspective: the Beaver Dam Eye Study. Br J Ophthalmol 2005:89:283-287.
Miller D: Pressure of the lid on the eye. Arch Ophthalmol 1967;78:328-330.
Asrani S, Zeimer R, Wilkensky J, et al: Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. J Glaucoma 2000;9:134-142.
Musch DC, Gillespie BW, Niziol LM, et al; the CIGTS Study Group: Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study. Ophthalmology 2011;118:1766-1773.
AGIS Investigators: The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000:130:429-440.
Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Gordon MO: The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002;120:701-713; discussion 829-830.
Mansouri K, Liu JHK, Weinreb RB, Tafreshi A, Medeiros FA: Analysis of continuous 24 h intraocular pressure patterns in glaucoma. Invest Ophthalmol Vis Sci 2012;53:8050-8056.
SENSIMED Triggerfish 2014. Lausanne, SENSIMED AG. http://www.sensimed.ch/en/sensimed-triggerfish/sensimed-triggerfish.html (accessed December 12, 2015).
Hjortdal JO, Jensen PK: In vitro measurement of corneal strain, thickness, and curvature using digital image processing. Acta Ophthalmol Scand 1995;73:5-11.
Liu H, Mansouri K, Weinreb RN: Estimation of 24-h intraocular pressure peak timing and variation using a contact lens sensor. PLoS One 2015;10:e0129529.
De Moraes CG, Jasien JV, Simon-Zoula S, Liebmann JM, Ritch R: Visual field change and 24-hour IOP-related profile with a contact lens sensor in treated glaucoma patients. Ophthalmology 2016, article in press.
Lee JW, Fu L, Shum JW, Chan JCh, Lai JS: Continuous 24-h ocular dimensional profile recording in medically treated normal-tension glaucoma. Clin Ophthalmol 2015;9:197-202.
Mansouri K, Weinerb RN, Liu JH: Effects of aging on 24-h intraocular pressure measurements in sitting and supine body positions. Invest Opthalmol Vis Sci 2012;53:112-116.
SENSIMED Triggerfish: Patient Booklet. SENSIMED Inc., Lausanne, Switzerland.
Choi J, Kim KH, Jeong J, Cho HS, Lee CH, Kook MS: Circadian fluctuation of mean ocular perfusion pressure is a consistent risk factor for normal-tension glaucoma. Invest Ophthalmol Vis Sci 2007;48:104-111.
Grippo TM, Liu JHK, Zebardast N, Arnold TB, Moore GH, Weinreb RN: Twenty-four-hour pattern of intraocular pressure in untreated patients with ocular hypertension. Invest Ophthalmol Vis Sci 2013;54:512-517.
Liu JH, Medeiros FA, Slight JR, Weinreb RN: Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure. Ophthalmology 2010;117:2075-2079.
Mansouri K, Weinreb RN, Medeiros FA: Is 24-h intraocular pressure monitoring necessary in glaucoma? Semin Ophthalmol 2013;28:157-164.
Tojo N, Abe S, Yagou T, Hayashi A: The fluctuation of intraocular pressure measured by a contact lens sensory in normal-tension glaucoma patients and nonglaucoma subjects. J Glaucoma 2016, E-pub ahead of print.
Friber TR, Sanborn G, Weinreb RN: Intraocular and episcleral venous pressure increase during inverted posture. Am J Opthalmol 1987;103:523-526.
Sunaric-Megevand G, Leuenberger P, Preussner PR: Assessment of the Triggerfish contact lens sensor for measurement of intraocular pressure variations. Acta Opthalmol 2014:92:e414-e415.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.